Minimal Residual Disease Testing Market: A $2.3 Billion
The global minimal residual disease testing market is poised to reach $2.3 billion by 2027, growing at a CAGR of 14.0% from 2022 to 2027.
© 2024 Crivva - Business Promotion. All rights reserved.